<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Oxtriphylline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01303</strong></td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Oxtriphylline is the choline salt form of theophylline. Once in the body, theophylline is released and acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Its main physiological reponse is to dilate the bronchioles. As such, oxytriphylline is indicated mainly for asthma, bronchospasm, and <span class="caps">COPD</span> (i.e. all the same indications as the other theophyllines). It is marketed under the name Choledyl SA, and several forms of oxytriphylline have been discontinued. In the US, oxtriphylline is no longer available.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01303/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01303/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01303.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01303.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01303.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01303.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01303.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01303">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Choline theophyllinate</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Choline theophylline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Choledyl</td><td>Warner Chilcott</td></tr><tr><td>Theocolin</td><td>Sannova</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/bronchodilator-agents">Bronchodilator Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>4499-40-5</td></tr><tr><th>Weight</th><td>Average: 283.3268<br>Monoisotopic: 283.164439563</td></tr><tr><th>Chemical Formula</th><td>C<sub>12</sub>H<sub>21</sub>N<sub>5</sub>O<sub>3</sub></td></tr><tr><th>InChI Key</th><td>RLANKEDHRWMNRO-UHFFFAOYSA-M</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3H,1-2H3,(H,8,9,12);7H,4-5H2,1-3H3/q;+1/p-1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(2-hydroxyethyl)trimethylazanium; 1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-ide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">C[N+](C)(C)CCO.CN1C2=C([N-]C=N2)C(=O)N(C)C1=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Superclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Class</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Alternative parents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Substituents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Classification description</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Used to treat the symptoms of asthma, bronchitis, COPD, and emphysema.</td></tr><tr><th>Pharmacodynamics</th><td>Oxtriphylline is a bronchodilator. Oxtriphylline works in several ways: it relaxes muscles in your lungs and chest to allow more air in, decreases the sensitivity of your lungs to allergens and other substances that cause inflammation, and increases the contractions of your diaphragm to draw more air into the lungs.</td></tr><tr><th>Mechanism of action</th><td>Oxtriphylline is a choline salt of theophylline. After ingestion, theophylline is released from oxytriphylline, and theophylline relaxes the smooth muscle of the bronchial airways and pulmonary blood vessels and reduces airway responsiveness to histamine, methacholine, adenosine, and allergen. Theophylline competitively inhibits type III and type IV phosphodiesterase (PDE), the enzyme responsible for breaking down cyclic AMP in smooth muscle cells, possibly resulting in bronchodilation. Theophylline also binds to the adenosine A2B receptor and blocks adenosine mediated bronchoconstriction. In inflammatory states, theophylline activates histone deacetylase to prevent transcription of inflammatory genes that require the acetylation of histones for transcription to begin.
</td></tr><tr><th>Absorption</th><td>After ingestion, theophylline is released from oxytriphylline in the acidic environment of the stomach. </td></tr><tr><th>Volume of distribution</th><td><p>Theophylline has an apparent volume of distribution of 0.3&#8211;0.7 L/kg in children and adults, and the Vd is about twice that of an adult in premature infants.</p></td></tr><tr><th>Protein binding</th><td>With a serum concentrations of 17 mcg/mL, adults and children have about 56% theophylline bound to plasma protein, and premature infants have about 36%.
</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Theophylline undergoes hepatic metabolism to 1,3-dimethyluric acid, 1-methyluric acid, and 3-methylxanthine.</p></td></tr><tr><th>Route of elimination</th><td>The kidneys are the main route of elimination for both theophylline and its metabolites, but some unchanged theophylline is eliminated in the feces.</td></tr><tr><th>Half life</th><td>The serum half life varies greatly between patients and in age. The half life range for a healthy, nonsmoking adult is 3-12.8 hours, for children is 1.5&#8211;9.5 hours, and for for premature infants is 15&#8211;58 hours.</td></tr><tr><th>Clearance</th><td><p>Theophylline has an average clearance in children (over 6 months) of 1.45 mL/kg per minute, and in healthy, nonsmoking adults of 0.65 mL/kg per hour.</p></td></tr><tr><th>Toxicity</th><td>Symptoms of toxicity include abdominal pain (continuing or severe), confusion or change in behavior, convulsions (seizures), dark or bloody vomit, diarrhea, dizziness or lightheadedness, fast and/or irregular heartbeat, nervousness or restlessness (continuing), and trembling (continuing).</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.585</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.7679</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.5861</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.718</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9763</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9261</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8496</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7126</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8089</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.5699</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7873</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.937</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9259</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9227</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9707</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9716</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.6337
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8347
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Ready biodegradable 
        </td>
        <td>
            0.9052
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.5809 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8706
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.8959
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Parke davis div warner lambert co</li>
<li>Morton grove pharmaceuticals inc</li>
<li>Watson laboratories inc</li>
<li>Warner chilcott bermuda ltd</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://ir.wcrx.com">Warner Chilcott Co. Inc.</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Elixir</td><td>Oral</td><td></td></tr><tr><td>Syrup</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet, extended release</td><td>Oral</td><td>400MG </td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Choledyl 20 mg/ml Elixir</td><td>0.04USD</td><td>ml</td></tr><tr><td>Pms-Oxtriphylline 20 mg/ml Elixir</td><td>0.02USD</td><td>ml</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>water solubility</td><td>Soluble in alcohol and water.</td><td>From Lexicomp.</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>3.84e+00 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-0.99</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-0.77</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-1.9</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>7.82</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>-0.78</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>66.4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>45.51</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>16.49</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Ladenburg, K., Duesel, B.F. and Fand,T.I.; U S . Patent 2,776,287; January 1,1957; assigned<br>
to Nepera Chemical Co., Inc.</p></span></td></tr><tr><th>General Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D02017" target="_blank">D02017 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=656652" target="_blank">656652 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46507376" target="_blank">46507376 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.571001.html" target="_blank">571001 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000868" target="_blank">DAP000868 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA164748137" target="_blank">PA164748137 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/mtm/oxtriphylline.html" target="_blank">http://www.drugs.com/mtm/oxtriphylline.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Oxtriphylline" target="_blank">Oxtriphylline <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>AHFS Codes</th><td><ul><li>86:16.00</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>MSDS</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00787">Aciclovir</a></td><td>Aciclovir may increase the effect and toxicity of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00640">Adenosine</a></td><td>This xanthine decreases the effect of adenosine</td></tr><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>The barbiturate, amobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>The barbiturate, aprobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00732">Atracurium</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>The barbiturate, butabarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>The barbiturate, butalbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>The barbiturate, butethal, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>Carbamazepine may decrease the serum concentration of oxtriphylline. Oxtriphylline may decrease the serum concentration of carbamazepine. Monitor for changes in the therapeutic effect of both agents if concomitant therapy is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00521">Carteolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00501">Cimetidine</a></td><td>Cimetidine may increase the serum concentration of oxtriphylline by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of oxtriphylline if cimetidine is initiated, discontinued or dose changed.</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>Ciprofloxacin may increase the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01211">Clarithromycin</a></td><td>Clarithromycin may increase the effect and toxicity of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01341">Dihydroquinidine barbiturate</a></td><td>The barbiturate, dihydroquinidine barbiturate, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00822">Disulfiram</a></td><td>Disulfiram may increase the effect and toxicity of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01135">Doxacurium chloride</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB00467">Enoxacin</a></td><td>Enoxacin may increase the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00199">Erythromycin</a></td><td>The macrolide, erythromycin, may increase the effect and toxicity of the theophylline derivative, oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00176">Fluvoxamine</a></td><td>Fluvoxamine may increase the therapeutic and adverse effects of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>Grepafloxacin may increase the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01159">Halothane</a></td><td>Increased risk of cardiac arrhythmia</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>The barbiturate, heptabarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>The barbiturate, hexobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00034">Interferon Alfa-2a, Recombinant</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00105">Interferon Alfa-2b, Recombinant</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00011">Interferon alfa-n1</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00951">Isoniazid</a></td><td>Isoniazid may increase the effect and toxicity of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01321">Josamycin</a></td><td>The macrolide, josamycin, may increase the effect and toxicity of the theophylline derivative, oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01356">Lithium</a></td><td>Theophylline decreases serum levels of lithium</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB01357">Mestranol</a></td><td>The contraceptive increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>The barbiturate, methohexital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>The barbiturate, methylphenobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01336">Metocurine</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB00379">Mexiletine</a></td><td>Mexiletine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01226">Mivacurium</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB01203">Nadolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>Norfloxacin may increase the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01337">Pancuronium</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB00487">Pefloxacin</a></td><td>Pefloxacin may increase the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00008">Peginterferon alfa-2a</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00022">Peginterferon alfa-2b</a></td><td>Interferon increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01359">Penbutolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>The barbiturate, pentobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00806">Pentoxifylline</a></td><td>Pentoxifylline increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The barbiturate, phenobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Decreased effect of both products</td></tr><tr><td><a href="/drugs/DB00960">Pindolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The barbiturate, primidone, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01182">Propafenone</a></td><td>Propafenone increases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00571">Propranolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>The barbiturate, quinidine barbiturate, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>Rifampin may decrease the effect and toxicity of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00503">Ritonavir</a></td><td>Ritonavir decreases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00533">Rofecoxib</a></td><td>Rofecoxib increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>The barbiturate, secobarbital, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00489">Sotalol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01323">St. John's Wort</a></td><td>St. John's Wort decreases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00382">Tacrine</a></td><td>Tacrine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>The barbiturate, talbutal, decreases the effect of oxtriphylline.</td></tr><tr><td><a href="/drugs/DB00857">Terbinafine</a></td><td>Terbinafine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00730">Thiabendazole</a></td><td>Thiabendazole increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00208">Ticlopidine</a></td><td>Ticlopidine increases the effect and toxicity of theophylline</td></tr><tr><td><a href="/drugs/DB00373">Timolol</a></td><td>Antagonism of action and increased effect of theophylline</td></tr><tr><td><a href="/drugs/DB01361">Troleandomycin</a></td><td>The macrolide, troleandomycin, may increase the effect and toxicity of the theophylline derivative, oxtriphylline.</td></tr><tr><td><a href="/drugs/DB01199">Tubocurarine</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB01339">Vecuronium</a></td><td>Theophylline decreases the effect of muscle relaxant</td></tr><tr><td><a href="/drugs/DB00661">Verapamil</a></td><td>Verapamil increases the effect of theophylline</td></tr><tr><td><a href="/drugs/DB00744">Zileuton</a></td><td>Zileuton increases the effect and toxicity of theophylline</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid high doses of caffeine.</li>
<li>Take with food to reduce irritation.</li></ul></td></tr></tbody></table>